Literature DB >> 16204007

Nanoparticle albumin-bound paclitaxel for metastatic breast cancer.

Mark Harries, Paul Ellis, Peter Harper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16204007     DOI： 10.1200/JCO.2005.08.002

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  21 in total

Review 1.  Recent developments in treatment stratification for metastatic breast cancer.

Authors:  Sarah Barton; Charles Swanton
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

2.  Encapsulating a Hydrophilic Chemotherapeutic into Rod-like Nanoparticles of a Genetically Encoded Asymmetric Triblock Polypeptide Improves its Efficacy.

Authors:  Jayanta Bhattacharyya; Isaac Weitzhandler; Shihan Bryan Ho; Jonathan R McDaniel; Xinghai Li; Lei Tang; Jinyao Liu; Mark Dewhirst; Ashutosh Chilkoti
Journal:  Adv Funct Mater       Date:  2017-02-07       Impact factor: 18.808

3.  Nanotechnology-based cancer therapeutics--promise and challenge--lessons learned through the NCI Alliance for Nanotechnology in Cancer.

Authors:  Dorothy Farrell; Krzysztof Ptak; Nicholas J Panaro; Piotr Grodzinski
Journal:  Pharm Res       Date:  2010-08-06       Impact factor: 4.200

Review 4.  One-component nanomedicine.

Authors:  Hao Su; Jin Mo Koo; Honggang Cui
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 5.  Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

Authors:  Mark J Ernsting; Mami Murakami; Aniruddha Roy; Shyh-Dar Li
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

Review 6.  Extracellular stability of nanoparticulate drug carriers.

Authors:  Karen C Liu; Yoon Yeo
Journal:  Arch Pharm Res       Date:  2013-11-12       Impact factor: 4.946

7.  Multifunctional albumin nanoparticles as combination drug carriers for intra-tumoral chemotherapy.

Authors:  Mingjie Cui; Dominik J Naczynski; Margot Zevon; Craig K Griffith; Larisa Sheihet; Izmarie Poventud-Fuentes; Suzie Chen; Charles M Roth; Prabhas V Moghe
Journal:  Adv Healthc Mater       Date:  2013-03-12       Impact factor: 9.933

8.  Polyactives: controlled and sustained bioactive release via hydrolytic degradation.

Authors:  N D Stebbins; J J Faig; W Yu; R Guliyev; K E Uhrich
Journal:  Biomater Sci       Date:  2015-06-02       Impact factor: 6.843

9.  Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.

Authors:  Isaac M Adjei; Blanka Sharma; Chiranjeevi Peetla; Vinod Labhasetwar
Journal:  J Control Release       Date:  2016-04-15       Impact factor: 9.776

Review 10.  Nanoparticles and their applications in cell and molecular biology.

Authors:  Edina C Wang; Andrew Z Wang
Journal:  Integr Biol (Camb)       Date:  2014-01       Impact factor: 2.192
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.